ArticleNature communications2024

Development of ISB 1442, a CD38 and CD47 bispecific biparatopic antibody innate cell modulator for the treatment of multiple myeloma.

C Grandclément et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.